Drug Trial Radar · NCT07326709
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
770
Planned (sponsor's estimate)
Start
Mar 24, 2026
Primary completion
Apr 2, 2030
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jan 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early symptomatic Huntington's disease (HD) compared to the control arm. HTT227 - current compound code (former code is PTC518 from PTC Therapeutics), HTT227 is Novartis code under Novartis sponsorship.
Conditions
- Huntington Disease
Interventions
Votoplam (blinded)Drug
Votoplam (blinded) active treatment
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in cUHDRS scoreTime frame: Baseline, Month 36
Locations
117 sites in 27 countries. Site status is shown where the registry gives one.
University of Alabama Birmingham
Birmingham, Alabama · Recruiting
Univ of Arkansas for Med Sciences
Little Rock, Arkansas · Recruiting
University of CA San Diego
La Jolla, California · Recruiting
UC Davis Health System
Sacramento, California · Recruiting
UCSF
San Francisco, California · Recruiting
Stanford Healthcare
Stanford, California · Recruiting
CenExcel Rocky Mtn Clin Research
Englewood, Colorado · Recruiting
U Conn Health
Farmington, Connecticut · Recruiting
Georgetown University
Washington D.C., District of Columbia · Recruiting
UM Department Of Neurology
Miami, Florida · Recruiting
University Of South Florida
Tampa, Florida · Recruiting
Grady Memorial Hospital and Clinics
Atlanta, Georgia · Recruiting
Parkinsons-Movement Disorder Ctr
Chicago, Illinois · Recruiting
Rush University Medical Center
Chicago, Illinois · Recruiting
Indiana University Health
Indianapolis, Indiana · Recruiting
University of Iowa Health Care
Iowa City, Iowa · Recruiting
University of Kansas Hospital
Fairway, Kansas · Recruiting
Hereditary Neurological Disease Centre
Wichita, Kansas · Recruiting
Johns Hopkins University
Baltimore, Maryland · Recruiting
Beth Israel Deaconess Med Ctr
Boston, Massachusetts · Recruiting
Henry Ford Health System
Detroit, Michigan · Recruiting
Trinity Health Michigan
Grand Rapids, Michigan · Recruiting
Albany Medical College
Albany, New York · Recruiting
UBMD Neurology
Buffalo, New York · Recruiting
Columbia University Irving Medical
New York, New York · Recruiting
Universi of Rochester School of Med
Rochester, New York · Recruiting
University Of NC At Chapel Hill
Chapel Hill, North Carolina · Recruiting
Duke University Health System
Durham, North Carolina · Recruiting
Cleveland Clinic Foundation
Cleveland, Ohio · Recruiting
Oregon Health Sciences University
Portland, Oregon · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
University Of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Veracity Neuroscience LLC
Memphis, Tennessee · Recruiting
Vanderbilt University Medical CenterX
Nashville, Tennessee · Recruiting
TX Movement Disorder Spec PLLC
Georgetown, Texas · Recruiting
U of TX Health Science Ct
Houston, Texas · Recruiting
The University of Vermont MC
Burlington, Vermont · Recruiting
VCU Health Systems MCV
Richmond, Virginia · Recruiting
University of Washington Medical Center
Seattle, Washington · Recruiting
Uni Of Wisconsin Hosp And Clinic
Madison, Wisconsin · Recruiting
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.